Publications by authors named "Mark Sale"

Claim this Profile
A
ADPO: automatic-differentiation-assisted parametric optimization.
Rong Chen, Mark Sale, Alex Mazur, Michael Tomashevskiy, Shuhua Hu

J Pharmacokinet Pharmacodyn· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pirana and Integrated PMX Tools, a Workbench for NONMEM, NLME, pyDarwin, and RsNLME.
Rong Chen, Mark Sale, James Craig, Michael Tomashevskiy, Alex Mazur

CPT Pharmacometrics Syst Pharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AI In Action: Redefining Drug Discovery and Development.
Anshul Kanakia, Mark Sale, Liang Zhao, Zhu Zhou

Clin Transl Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization.
Xinnong Li, Mark Sale, Keith Nieforth, James Craig, Fenggong Wang

J Pharmacokinet Pharmacodyn· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed-Effect Model Selection Toolbox.
Xinnong Li, Mark Sale, Keith Nieforth, Kristin L Bigos, James Craig

Clin Pharmacol Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA.
Lanyan Fang, Yuqing Gong, Andrew C Hooker, Viera Lukacova, Amin Rostami-Hodjegan, Mark Sale

AAPS J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer.
Mingxiang Liao, Jie Zhou, Kenton Wride, Denise Lepley, Terri Cameron, Mark Sale

Eur J Drug Metab Pharmacokinet· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Drug-Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer.
Chao Li, Janet K Horton, Mark Sale, Laura Curd, Vineet Goti

Clin Drug Investig· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection.
Mohamed Ismail, Mark Sale, Yifan Yu, Nikhil Pillai, Sihang Liu

J Pharmacokinet Pharmacodyn· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema.
Amanda Mathis, Mark Sale, Melanie Cornpropst, William P Sheridan, Shu Chin Ma

Clin Transl Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemia.
Xia Pu, Mark Sale, Feng Yang, Yi Zhang, John D Davis

CPT Pharmacometrics Syst Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
Chao Li, Lowell Hart, Taofeek K Owonikoko, Raid Aljumaily, Caio Max Rocha Lima, Mark Sale

Cancer Chemother Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight-Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy.
Cuiping Chen, Carol L Rosen, Chad Ruoff, Leslie H Boyce, Rupa Parvataneni, Mark Sale

Clin Transl Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir Plasma Concentration from Preexposure Prophylaxis at the Time of Potential HIV Exposure: a Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa.
Surulivelrajan Mallayasamy, Ayyappa Chaturvedula, Michael J Fossler, Mark Sale, Vineet Goti

Antimicrob Agents Chemother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
Ayyappa Chaturvedula, Stacie Calad-Thomson, Chao Liu, Mark Sale, Nandu Gattu

CPT Pharmacometrics Syst Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach.
Surulivelrajan Mallayasamy, Ayyappa Chaturvedula, Michael J Fossler, Mark E Sale, Craig W Hendrix

Front Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution.
Domenic A Sica, Pieter Muntendam, Rene L Myers, Jozine M Ter Maaten, Mark E Sale

JACC Basic Transl Sci· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis.
Kumpal Madrasi, Ayyappa Chaturvedula, Jessica E Haberer, Mark Sale, Michael J Fossler

J Clin Pharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods.
Yanhui Lu, Vineet Goti, Ayyappa Chaturvedula, Jessica E Haberer, Michael J Fossler, Mark E Sale

Antimicrob Agents Chemother· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
David T Rubin, William J Sandborn, Brian Bosworth, Salam Zakko, Glenn L Gordon, Mark E Sale

Dig Dis Sci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selection.
Mark Sale, Eric A Sherer

Br J Clin Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis.
Herbert Struemper, Mark Sale, Bela R Patel, Mikkel Østergaard, Anders Österborg

J Clin Pharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic algorithm guided population pharmacokinetic model development for simvastatin, concurrently or non-concurrently co-administered with amlodipine.
Ayyappa Chaturvedula, Mark E Sale, Howard Lee

J Clin Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.
Eric A Sherer, Mark E Sale, Bruce G Pollock, Chandra P Belani, Merrill J Egorin

J Pharmacokinet Pharmacodyn· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months.
John T Mondick, Brendan M Johnson, Lynda J Haberer, Mark E Sale, Peter C Adamson

Eur J Clin Pharmacol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis